Table 1.
Clinical characteristics of patients with COVID associated lower urinary tract symptoms.
| Patient # | Age (years) | Sex | Acute/MIS-C | Onset of CALUTS (weeks) | Duration of CALUTS (months) | Pre-COVID BBDQ | Per-CALUTS BBDQ | Per-CALUTS Incontinence | Other symptoms |
Hospitalization | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fever | Respa | GISb | ||||||||||
| 1 | 6 | M | MIS-C | 4 | 6 | 1 | 26 | + | + | + | – | + (+ICU) |
| 2 | 16 | M | MIS-C | 0 | 3 | 1 | 16 | – | + | – | – | + |
| 3 | 14 | M | Acute | 0 | 3 | 1 | 15 | – | + | – | + | – |
| 4 | 16 | F | Acute | 2 | 1 | 3 | 15 | – | – | + | – | – |
| 5 | 17 | M | Acute | 0 | 1 | 1 | 15 | – | + | – | – | – |
| 6 | 11 | F | Acute | 1 | 1 | 3 | 23 | + | – | + | – | – |
| 7 | 11 | F | Acute | 1 | 3 | 1 | 23 | + | + | + | – | – |
| 8 | 12 | F | Acute | 2 | 3 | 1 | 24 | + | + | – | – | – |
| 9 | 11 | F | Acute | 0 | 6 | 1 | 15 | – | – | + | – | – |
| 10 | 12 | M | Acute | 0 | 3 | 3 | 24 | + | + | – | + | – |
| 11 | 5 | F | Acute | 11 | 1 | 18 | 23 | + | + | + | – | + |
| 12 | 15 | F | Acute | 1 | 3 | 2 | 15 | – | + | + | + | – |
| 13 | 17 | M | Acute | 0 | 1 | 6 | 18 | – | + | – | – | – |
| 14 | 14 | F | Acute | 0 | 1 | 3 | 15 | – | + | + | + | – |
| 15 | 4 | F | Acute | 0 | 3 | 1 | 21 | + | + | + | + | + |
| 16 | 6 | F | Acute | 0 | 1 | 5 | 24 | + | + | – | – | – |
| 17 | 17 | F | Acute | 2 | 3 | 2 | 28 | + | + | – | + | – |
| 18 | 4 | M | Acute | 4 | 3 | 5 | 17 | + | + | + | – | – |
| 19 | 6 | F | Acute | 1 | 3 | 14 | 29 | + | + | + | + | + |
| 20 | 4 | F | Acute | 1 | 3 | 3 | 28 | + | + | + | + | + |
a
Resp: respiratory symptoms.
b
Gastrointestinal symptoms.